Andreza Ketly DA Silva Araújo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andreza Ketly DA Silva Araújo has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Jand Venes Rolim Medeiros
Universidade Federal do Delta do Parnaíba
3 shared publications - André Luis Fernandes Lopes
Universidade Federal do Delta do Parnaíba, Brasil
2 shared publications - Gabriella Pacheco
Laboratory of Inflammation and Translational Gastroenterology (LIGAT), Post-graduation Program in Biotechnology (PPGBIOTEC), Parnaíba Delta Federal University, Av. São Sebastião, 2819, Parnaíba, PI, CEP 64202-020, Brazil
2 shared publications - Katriane Carvalho da Silva
Universidade Federal do Delta do Parnaíba
2 shared publications - Lucas Antonio Duarte Nicolau
Universidade Federal do Delta do Parnaíba, Brasil
2 shared publications - Marcelo Biondaro Gois
Faculdade de Ciências da Saúde, Universidade Federal de Rondonópolis, Rondonópolis 78736-900, MT, Brazil
2 shared publications
Latest Publications
- Open Access
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 59
Alpha-ketoglutarate supplementation ameliorates castor oil-induced diarrhea in mice: in silico and in vivo insights
Alpha-ketoglutarate (α-kg) is an intermediate of the Krebs cycle and a precursor of glutamine and glutamate. Furthermore, α-kg contributes to the maintenance of intestinal barrier integrity. Diarrhea, a global health problem, is characterized by an increased frequency and liquidity of bowel movements and is closely associated with impaired intestinal function. As oral rehydration is the primary treatment modality available, the present study evaluated the antidiarrheal potential of α-kg in castor oil (CO)-induced diarrhea model and investigated its molecular interactions through in silico modeling. Molecular docking was performed to assess the binding affinity of α-kg with CFTR (3SI7), CaCC (5OYB), and Na+/K+-ATPase (3B8E). For the in vivo experiments, mice were divided into the following groups: vehicle, α-kg (120, 60, and 30 mg/kg), CO (10 mL/kg), and loperamide (5 mg/kg). α-kg was administered orally for five consecutive days. On the fifth day, one hour after the final dose, diarrhea was induced with CO. The loperamide group was pre-treated with loperamide prior to CO administration, whereas the CO group received only CO, and the vehicle group received distilled water. After four hours, the animals were euthanized, and the intestinal samples were collected to evaluate intestinal content, chloride ion levels, and oxidative stress markers (malondialdehyde, glutathione, and nitrite). α-kg reduced fecal outputs, intestinal fluid secretion, and oxidative stress markers, while enhancing Na+/K+-ATPase activity, preserving glutathione levels, and improving histomorphometric parameters and mucin content. In conclusion, α-kg exhibited favorable binding interactions with key molecular, antidiarrheal, and antioxidant effects, and restored intestinal histological parameters.
- 1 January 2026
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 59
Open AccessAlpha-ketoglutarate supplementation ameliorates castor oil-induced diarrhea in mice: in silico and in vivo insights
Alpha-ketoglutarate (α-kg) is an intermediate of the Krebs cycle and a precursor of glutamine and glutamate. Furthermore, α-kg contributes to the maintenance of intestinal barrier integrity. Diarrhea, a global health problem, is characterized by an increased frequency and liquidity of bowel movements and is closely associated with impaired intestinal function. As oral rehydration is the primary treatment modality available, the present study evaluated the antidiarrheal potential of α-kg in castor oil (CO)-induced diarrhea model and investigated its molecular interactions through in silico modeling. Molecular docking was performed to assess the binding affinity of α-kg with CFTR (3SI7), CaCC (5OYB), and Na+/K+-ATPase (3B8E). For the in vivo experiments, mice were divided into the following groups: vehicle, α-kg (120, 60, and 30 mg/kg), CO (10 mL/kg), and loperamide (5 mg/kg). α-kg was administered orally for five consecutive days. On the fifth day, one hour after the final dose, diarrhea was induced with CO. The loperamide group was pre-treated with loperamide prior to CO administration, whereas the CO group received only CO, and the vehicle group received distilled water. After four hours, the animals were euthanized, and the intestinal samples were collected to evaluate intestinal content, chloride ion levels, and oxidative stress markers (malondialdehyde, glutathione, and nitrite). α-kg reduced fecal outputs, intestinal fluid secretion, and oxidative stress markers, while enhancing Na+/K+-ATPase activity, preserving glutathione levels, and improving histomorphometric parameters and mucin content. In conclusion, α-kg exhibited favorable binding interactions with key molecular, antidiarrheal, and antioxidant effects, and restored intestinal histological parameters.
- 21 October 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 960, 176118
Protective effect of alpha-ketoglutarate against water-immersion restraint stress-induced gastric mucosal damage in mice
- 21 October 2023
- Published by Elsevier in European Journal of Pharmacology
- Vol. 960, 176118
Protective effect of alpha-ketoglutarate against water-immersion restraint stress-induced gastric mucosal damage in mice
- Open Access
- 22 September 2023
- Published by Instituto Multiprofissional de Ensino
- Vol. 4 (3) , 737-742
PERFIL SOCIODEMOGRÁFICO DE PACIENTES COM COVID-19 QUE FIZERAM USO DO KIT COVID BRASILEIRO
INTRODUÇÃO: A pandemia de COVID-19 desencadeou uma corrida global em busca de ferramentas terapêuticas para tratar a doença. Mesmo sem evidências científicas robustas que comprove a eficácia, as prescrições, vendas e consumo de associações medicamentosas como o KitCovid Brasileiro composto pela azitromicina, hidroxicloroquina e ivermectina aumentaram significamente. OBJETIVO: Descrever o perfil sociodemográfico de indivíduos com diagnóstico positivo para COVID-19 que residem na Macrorregião litorânea do Piauí e fizeram uso do Kit Covid. MÉTODOS: Foi realizado um estudo epidemiológico transversal analítico e quantitativo em pacientes com diagnóstico confirmado para COVID-19. Os participantes foram submetidos a um questionário sociodemográfico para avaliar possíveis correlações sociodemográficas e adesão ao uso dos medicamentos. RESULTADOS: Foram incluídos na pesquisa 48 pacientes sem tratamento e 78 pacientes com tratamento. O sexo feminino foi prevalente entre os participantes. A renda familiar está diretamente ligada a utilização da terapia farmacológica. CONCLUSÃO: O presente estudo demonstrou que a maioria dos pacientes que aderiram ao uso do kit covid eram indivíduos que possuíam a renda familiar mais baixa e o número amostral do estudo se mostrou extremamente promissor para realização de futuros estudos.
- 22 September 2023
- Published by Instituto Multiprofissional de Ensino
- Vol. 4 (3) , 737-742
Open AccessPERFIL SOCIODEMOGRÁFICO DE PACIENTES COM COVID-19 QUE FIZERAM USO DO KIT COVID BRASILEIRO
INTRODUÇÃO: A pandemia de COVID-19 desencadeou uma corrida global em busca de ferramentas terapêuticas para tratar a doença. Mesmo sem evidências científicas robustas que comprove a eficácia, as prescrições, vendas e consumo de associações medicamentosas como o KitCovid Brasileiro composto pela azitromicina, hidroxicloroquina e ivermectina aumentaram significamente. OBJETIVO: Descrever o perfil sociodemográfico de indivíduos com diagnóstico positivo para COVID-19 que residem na Macrorregião litorânea do Piauí e fizeram uso do Kit Covid. MÉTODOS: Foi realizado um estudo epidemiológico transversal analítico e quantitativo em pacientes com diagnóstico confirmado para COVID-19. Os participantes foram submetidos a um questionário sociodemográfico para avaliar possíveis correlações sociodemográficas e adesão ao uso dos medicamentos. RESULTADOS: Foram incluídos na pesquisa 48 pacientes sem tratamento e 78 pacientes com tratamento. O sexo feminino foi prevalente entre os participantes. A renda familiar está diretamente ligada a utilização da terapia farmacológica. CONCLUSÃO: O presente estudo demonstrou que a maioria dos pacientes que aderiram ao uso do kit covid eram indivíduos que possuíam a renda familiar mais baixa e o número amostral do estudo se mostrou extremamente promissor para realização de futuros estudos.